HIGHLIGHTS
- who: TYPE and colleagues from the INSERM , Institut Cochin, France University of Siena, Italy have published the article: The role of angiogenesis in melanoma: Clinical treatments and future expectations, in the Journal: (JOURNAL)
- what: The study is currently being carried out in patients with anti-PD1-resistant melanoma (NCT02298959) (Rahma et_al, 2022).
- how: Showed that the overall survival (OS) at 5 years of the two groups was 64%. Showed that the PFS of the combination group was 6.9 months and that of the IL-2 alone group was 2.3 months. To . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.